Articles Posted in Syngenta

EC Approves ChemChina’s Acquisition of Syngenta
Doyle, Barlow & Mazard PLLC

On April 5, 2017, the EC approved China National Chemical Corporation’s (“ChemChina”) proposed acquisition of  Syngenta AG (“Syngenta).  The approval is conditional on the divestiture of significant parts of ChemChina’s European pesticide and plant growth regulator business. Syngenta is the leading pesticide supplier worldwide. ChemChina is currently active in pesticide markets in Europe through Adama,…

Continue reading ›
FTC Approves ChemChina’s Acquisition of Syngenta
Doyle, Barlow & Mazard PLLC

On April 4, 2017, the FTC entered into a settlement agreement with China National Chemical Corporation (“ChemChina”) and Syngenta AG whereby the parties agreed to divest three types of pesticides, in order to resolve antitrust concerns with its merger. Syngenta is the leading pesticide supplier worldwide. ChemChina is currently active in pesticide markets in the…

Continue reading ›
Senator Grassley Calls For Hearings on Consolidation of Seed and Ag Chemical Industry
Doyle, Barlow & Mazard PLLC

On August 23, 2016, Senate Judiciary Committee Chairman Chuck Grassley announced a hearing on the increasing consolidation within the seed and chemical industry. The hearing will be held in late September.  Senator Grassley said that “The seed and chemical industries are critical to agriculture and the nation’s economy, and Iowans are concerned that this sudden…

Continue reading ›
Senator Grassley Urging the FTC and DOJ to Coordinate Reviews of Seed Mergers
Doyle, Barlow & Mazard PLLC

On August 16, 2016, Senator Charles Grassley (R-IA), chairman of the Senate Judiciary Committee, wrote a letter to FTC Chairwoman Edith Ramirez and DOJ Antitrust Division Head, Renata Hesse in which he expressed concerns regarding two major mergers in agricultural technology and seeds that could potentially hurt competition in the industry and make it harder…

Continue reading ›
Aerial view of Washington DC cityscape from Arlington Virginia USA.

Contact Us

Fill out the form or call us at (202) 589-1834 to schedule your consultation.